Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kienast

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Journal of the American College of Cardiology|October 1, 1993
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis GroupM Verstraete, M Nurmohamed, J Kienast, et al.
Journal of Cardiovascular Pharmacology|September 1, 1993
Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteersG A Marbet, M Verstraete, J Kienast, et al.
Endoscopy|July 18, 2008
Intestinal graft-versus-host-disease staging by video capsule endoscopyT Meister, H Heinzow, G Bisping, et al.
Blood|February 7, 2001
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myelomaB Dankbar, T Padró, R Leo, et al.
Blood|February 7, 2001
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemiaT Padró, S Ruiz, R Bieker, et al.
Coronary Artery Disease|November 1, 1994
Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group)P Close, J Bichler, R Kerry, et al.
Leukemia|October 8, 2004
Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysisC Scheffold, M Kroeger, M Zuehlsdorf, et al.
Journal of the American College of Cardiology|November 14, 1997
Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registryW Kasper, S Konstantinides, A Geibel, et al.
Thrombosis and Haemostasis|April 8, 1998
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteriesJ Kienast, T Padró, M Steins, et al.
Journal of Orthopaedic Surgery and Research|September 20, 2011
Biomechanical analysis of a synthetic femoral spiral fracture model: Do end caps improve retrograde flexible intramedullary nail fixation?Martin M Kaiser, Gregor Zachert, Robert Wendlandt, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|October 1, 1993
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis GroupM Verstraete, M Nurmohamed, J Kienast, et al.
Journal of Cardiovascular Pharmacology|September 1, 1993
Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteersG A Marbet, M Verstraete, J Kienast, et al.
Endoscopy|July 18, 2008
Intestinal graft-versus-host-disease staging by video capsule endoscopyT Meister, H Heinzow, G Bisping, et al.
Blood|February 7, 2001
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myelomaB Dankbar, T Padró, R Leo, et al.
Blood|February 7, 2001
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemiaT Padró, S Ruiz, R Bieker, et al.
Coronary Artery Disease|November 1, 1994
Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group)P Close, J Bichler, R Kerry, et al.
Leukemia|October 8, 2004
Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysisC Scheffold, M Kroeger, M Zuehlsdorf, et al.
Journal of the American College of Cardiology|November 14, 1997
Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registryW Kasper, S Konstantinides, A Geibel, et al.
Thrombosis and Haemostasis|April 8, 1998
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteriesJ Kienast, T Padró, M Steins, et al.
Journal of Orthopaedic Surgery and Research|September 20, 2011
Biomechanical analysis of a synthetic femoral spiral fracture model: Do end caps improve retrograde flexible intramedullary nail fixation?Martin M Kaiser, Gregor Zachert, Robert Wendlandt, et al.
Pageof 9